Key result
Vasopressin increases renal sensory neuron excitability at lower doses in female versus male cells.
Why the study?
The underlying cause of elevated renal sensory nerve activity in cardiovascular and kidney diseases remained unclear, and the role of vasopressin had not been tested.
Does vasopressin increase the excitability of renal-specific dorsal root ganglia neurons in male and female rats?
Does vasopressin increase the excitability of renal-specific dorsal root ganglia neurons in male and female rats?
Vasopressin directly increases the excitability of renal sensory neurons, providing a potential mechanism for elevated peripheral sensory nerve activity in diseases such as hypertension and polycystic kidney disease.
Hypothesis-generating for vasopressin in renal afferents; human studies needed before clinical relevance.
BACKGROUND: Preclinical models of cardiovascular and kidney diseases, such as hypertension and polycystic kidney disease (PKD), are associated with increased vasopressin (AVP) and increased renal afferent nerve activity (ARNA). We have also shown that ablation of renal sensory nerves can mitigate HTN and PKD progression in preclinical models. Yet, the underlying cause of elevated renal sensory nerve activity in disease remains unclear, and the role of vasopressin remains untested. Therefore, we hypothesized that AVP would increase the excitability of renal-specific dorsal root ganglia neurons (rDRGN) in both male and female rats. METHODS: To address this hypothesis, rDRGN were isolated from both male and female Sprague-Dawley (SD) rats and cell excitability changes with AVP were measured by whole-cell patch clamp in current-clamp mode. Excitability was quantified by mean action potential (AP) frequency, rheobase, and multi-firing threshold. Dose-dependent responses to AVP (10-12-10-6M) were measured and compared to vehicle (saline). RESULTS: Cell excitability was increased by AVP in both male and female cells, increasing AP frequency and lowering rheobase and multi-firing threshold. The effective excitatory range of AVP was 10-10-10-6M in female cells, and 10-8-10-6M in males. CONCLUSIONS: These experiments support our initial hypothesis that AVP would directly increase rDRGN excitability. This excitatory effect may support a novel role through which peripheral sensory nerves interact with and respond to AVP. In turn, this AVP-ARNA interaction may contribute to elevated peripheral sensory nerve activity and disease progression where AVP is elevated, such as hypertension and PKD.
No takes yet. Share an insight, caveat, or question.
Hayoz et al. (2026) studied this question. Vasopressin (AVP) vs. Vehicle (saline) was evaluated on Cell excitability (mean action potential frequency, rheobase, and multi-firing threshold). Vasopressin increased the excitability of renal sensory neurons, with an effective excitatory range of 10-10 to 10-6M in female cells and 10-8 to 10-6M in male cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: